The Food and Drug Administration (FDA) has expanded the approval of Nerivio ® (Theranica) to include the acute and/or ...

Theranica, a prescribed neuromodulation therapeutics company, today announced the Nerivio® REN wearable received an expanded age indication from the FDA for use in patients aged eight and above, ...

In children, it’s more likely to affect both sides. Symptoms can vary, but they may include: Most treatments for migraine work best when used as soon as possible after symptoms appear.

Children with vestibular migraine often have a family history ... and any co-existing medical conditions. Treatment typically lasts several months, but the medications may be adjusted based ...

In the present study, we explored whether headache drawings correlate with clinical improvement after treatment in children with migraine headaches followed longitudinally. Children seen in the ...

He said a doctor should be consulted when daily life is impacted by migraines or when frequency is more than once a week, so ...

Those who received the highest dose had, on average, six fewer migraine days in the four weeks following the treatment than they did before receiving the medication, compared to a drop by only ...

This injectable formulation of sumatriptan, designed for acute migraine treatment, could provide ... or Tosymra are safe and effective in children under 18 years of age. Important Safety ...

Children aged eight and up now have a prescribed non-drug option to treat migraine early and potentially prevent long-term disability and disease progression, addressing a critical unmet need in ...